Intrathecal Hydrocortisone in the Treatment of Tuberculous Meningitis (Preliminary Report)

Harsoyo N. (Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java)
Moeljono S. Trastotenojo (Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java)
Soejono Soejono (Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java)
Dedy Abubakar (Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java)
Indra Warman (Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java)

Paediatrica Indonesiana
Vol 16 No 9-10 (1976): September - October 1976

A trial on the treatment of tuberculous meningitis with intrathecal hydrocortisone, beside INH, PAS, and Streptomycin, performed at the Dr. Kariadi General Hospital in October 1972, is reported. Eighteen patients were treated, giving good results; 5.6% mortality were noted. A great number of complications of optic nerve atrophy (61.1 %) were found and 22.2% with early atrophy recovered. The results are better compared with those of Choremis et al. (1957) who found a mortality of 13.7% among 29 patients with tuberculous meningitis treated in the same way, except P.A.S.